Growth factors
SECONDARY, FEBRILE NEUTROPENIA
Hematopoietic growth factors (i.e., G-CSF) may be used according to institutional guidelines to treat febrile neutropenia, but should not be used as primary or secondary prophylaxis. Growth factors must be discontinued at least 48 h prior to initiation of the next treatment of chemotherapy.